Using Evidence-based Medicine to Determine Risks and Public Policy

Dr Paul Alexander highlights the importance of following the data to determine personal risk and guide public policy.

Media, NEW: Children & Youths, NEW: Early Treatment, NEW: Featured, NEW: Knowledge Base, NEW: Mental Health, NEW: Pandemic Management, NEW: Prevention & Treatment, NEW: Real World Data, NEW: Vaccines, NEW: Virus & Variants
ACE-2, asymptomatic, children, comorbidities, COVID, diabetes, Doctor Talks, Dr. Paul Alexander, early outpatient therapy, elderly, evidence-based, evidence-based medicine, false positive, Fauci, infection fatality rate, isolate, lockdowns, McMaster, median age of death, mental health, obesity, pandemic management, public policy, Risk, risk factors, SARS, schools, USA, vaccines, Video, WHO, youth

The Blind Spot in COVID-19 Vaccination Policies: Under Reported Adverse Events

In this peer-reviewed publication, Dr Patrick Provost examines the post-vaccination adverse events reporting system and the inherent weaknesses that may result in underreporting. Based on

A 6-Week Time Period May not be Sufficient to Identify Potential Adverse Events Following COVID-19 Vaccination

Drs Prevost and Banoun have published a peer-reviewed article advocating for extension of the timeline to accept entries into the adverse event reporting systems for

Canadians Injured by mRNA Vaccines Speak Out

We are honoured to share with you a new CCCA video series in which fellow Canadians share their stories of being injured after receiving the COVID-19 mRNA vaccines

Using Evidence-based Medicine to Determine Risks and Public Policy

Using Evidence-based Medicine to Determine Risks and Public Policy

Related Posts

A 6-Week Time Period May not be Sufficient to Identify Potential Adverse Events Following COVID-19 Vaccination

Canadian Covid Care Alliance